Melody PB1016 Surveillance Study

NCT ID: NCT02347189

Last Updated: 2019-11-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

39 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2018-08-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Non-randomized, multi-center, prospective surveillance study to investigate and assess the residual risks, and to confirm the currently established safety and performance of the Melody TPV PB1016.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dysfunctional RVOT Conduits in Patients With Congenital Heart Defects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Melody TPV PB1016

Group Type OTHER

Melody Transcatheter Pulmonary Valve PB1016

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Melody Transcatheter Pulmonary Valve PB1016

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient eligible to receive Melody TPV PB1016 per current Instructions for Use (IFU) indications at time of study enrollment
* Patient (or patient's legally authorized representative) is willing to consent to participate in the study and will commit to completion of all follow-up requirements.

Exclusion Criteria

* Implantation in the aortic, tricuspid, or mitral position
* Venous anatomy unable to accommodate a 22-Fr size introducer sheath
* Obstruction of the central veins
* Clinical or biological signs of infection including active endocarditis
* History of intravenous substance abuse
* Currently participating in an investigational drug or device study
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic Heart Valves

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California - Los Angeles

Los Angeles, California, United States

Site Status

Children's Hospital of Michigan

Detroit, Michigan, United States

Site Status

Nationwide Childrens Hospital

Columbus, Ohio, United States

Site Status

Primary Children's Hospital

Salt Lake City, Utah, United States

Site Status

Seattle Childrens and Regional Hospital

Seattle, Washington, United States

Site Status

Landes-Kinderklinik

Linz, , Austria

Site Status

Stollery Childrens Hospital

Edmonton, Alberta, Canada

Site Status

Hospital General Universitario Gregorio Marañón

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Austria Canada Spain

References

Explore related publications, articles, or registry entries linked to this study.

Morray BH, Jones TK, Coe JY, Gitter R, Martinez JZ, Turner DR, Gray RG, Lung TH, Berman DP, Levi DS. Implantation of the Melody transcatheter pulmonary valve PB1016 in patients with dysfunctional right ventricular outflow tract conduits. Catheter Cardiovasc Interv. 2019 Feb 15;93(3):474-480. doi: 10.1002/ccd.27974. Epub 2018 Nov 12.

Reference Type DERIVED
PMID: 30419603 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10154745DOC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Harmony TPV EMEA PMS
NCT06906926 RECRUITING NA